Fluoxymesterone is an oral androgen, a 17-alpha-methylated, fluorinated derivative of testosterone. It was sold in the US as Halotestin tablets.
Also known as: Halotestin, Android-F, Ora-Testryl.
Halotestin came as 2 mg, 5 mg and 10 mg scored tablets. Drugs@FDA lists Halotestin and the US generics as discontinued.
The Halotestin label (2002) indicated fluoxymesterone for testosterone replacement in men with primary or secondary hypogonadism, for confirmed delayed puberty, and for palliation of certain hormone-dependent breast cancers in women. For replacement in men it gave 5 to 20 mg daily, taken at once or split into three or four doses. Drugs@FDA lists Halotestin and every US generic fluoxymesterone application as discontinued.
Anabolic steroids are Schedule III controlled substances in the US. Use without a prescription is illegal, and the labels warn about liver damage (including peliosis hepatis and liver tumors), cholesterol changes and suppression of the body's own testosterone and sperm production.
The Halotestin label says the half-life of fluoxymesterone after a dose by mouth is about 9.2 hours; Dose Track uses 9.5 hours. The label gives no time to peak.
Numbers shown are the values Dose Track uses, listed only where they agree with the source above. Half-life varies from person to person and with injection site.